Let’s Talk Retina: an Evolve Medical Education Podcast
Evolve Medical Education, LLC
15 episodes
8 months ago
This podcast features subject matter experts from around the globe discussing all things retina, including diagnosis of retinal diseases, advanced imaging, and cutting-edge medical and surgical treatments, with candid conversations about the future of retinal disease therapies.
All content for Let’s Talk Retina: an Evolve Medical Education Podcast is the property of Evolve Medical Education, LLC and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
This podcast features subject matter experts from around the globe discussing all things retina, including diagnosis of retinal diseases, advanced imaging, and cutting-edge medical and surgical treatments, with candid conversations about the future of retinal disease therapies.
GA Perspectives: Dry AMD Follow-Up and a Patient With Advanced Glaucoma and History of Retinal Detachment
Let’s Talk Retina: an Evolve Medical Education Podcast
12 minutes
2 years ago
GA Perspectives: Dry AMD Follow-Up and a Patient With Advanced Glaucoma and History of Retinal Detachment
Roger A. Goldberg, MD, MBA, presents two cases: presents two cases: an 111-year-old patient who presents for a dry age-related macular degeneration follow-up and a patient with geographic atrophy who also has advanced glaucoma and a history of retinal detachment.
This activity is supported by an independent medical education grant from Apellis Pharmaceuticals.
Click here to view Dr. Goldberg's webinar event, which includes images from the talk.
Check out the central hub of this webinar series.
Want to register with Evolve Medical Education? Click here.
Let’s Talk Retina: an Evolve Medical Education Podcast
This podcast features subject matter experts from around the globe discussing all things retina, including diagnosis of retinal diseases, advanced imaging, and cutting-edge medical and surgical treatments, with candid conversations about the future of retinal disease therapies.